Revenue
2023
2025
Adagio Medical Holdings, Inc. (ADGM)
Price—Loading quote
Net income
2023
2025
Free cash flow
2023
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2023 | |
|---|---|---|
| Revenue | $0 | $300,000 |
| Research & development | $10.6M | $15.4M |
| Operating income | −$21.9M | −$27.9M |
| EBITDAderived | −$20.9M | −$27.4M |
| Net income | −$25.1M | −$36.6M |
| Basic EPSper diluted share | -$1.51 | -$48.16 |
| Diluted EPSper diluted share | -$1.51 | -$48.16 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 16, 2025Form 4 | Kaster DeborahChief Financial Officer | BuyCommon Stock | 15.0K | $1.20 | $18.0K | 15.0K |
| Dec 12, 2025Form 4 | Usen ToddChief Executive Officer | BuyCommon Stock | 207.3K | $1.09 | $226.0K | 207.3K |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyPre-Funded Warrant (right to buy) · derivative · indirect | 2.19M | $1.60 | $3.50M | 2.19M |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyTranche C Warrant ("Common Warrant" right to buy) · derivative · indirect | 1.34M | $0.18 | $242.1K | 1.34M |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyTranche B Warrant ("Common Warrant" right to buy) · derivative · indirect | 1.34M | $0.18 | $242.1K | 1.34M |